[
  {
    "jumpto": "ENAS5567_4.3.1.0",
    "name": "A1C and CVD outcomes [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_2.3.0.0",
    "name": "A1C and mean glucose [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_4.2.0.0",
    "name": "A1C and microvascular complications, ACCORD, ADVANCE, and VADT [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_2.4.0.0",
    "name": "A1C differences, children [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_2.4.0.0",
    "name": "A1C differences, ethnic populations [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_4.1.0.0",
    "name": "A1C goals, overview [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5575_3.4.0.0",
    "name": "A1C in pregnancy [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5567_2.2.0.0",
    "name": "A1C limitations [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "interactive_0001690",
    "name": "A1C target individualization [tool]"
  },
  {
    "jumpto": "ENAS5567_2.1.0.0",
    "name": "A1C testing, recommendations [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_4.2.0.0",
    "name": "ACCORD, ADVANCE, and VADT [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5565_4.4.0.0",
    "name": "ACCORD trial [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_10.0.0.0",
    "name": "Acute care setting, transition [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5572_1.6.0.0",
    "name": "Acute kidney injury [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5569_6.2.0.0",
    "name": "Adverse effects [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5577_2.2.0.0",
    "name": "Advocacy position statements [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5569_3.2.0.0",
    "name": "AHEAD trial [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5572_1.3.0.0",
    "name": "Albuminuria, assessment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5566_3.10.0.0",
    "name": "Alcohol [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5576_5.2.1.0",
    "name": "Antihyperglycemic agents in hosp. pts., insulin therapy [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_5.3.0.0",
    "name": "Antihyperglycemic agents in hosp. pts., noninsulin therapies [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_5.1.0.0",
    "name": "Antihyperglycemic agents in hosp. pts., recommendations [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5571_5.5.0.0",
    "name": "Antihyperglycemic therapies and cardiovascular outcomes [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "interactive_0001689",
    "name": "Antihyperglycemic therapy in T2DM [tool]"
  },
  {
    "jumpto": "ENAS5569_4.2.0.0",
    "name": "Antihyperglycemic therapy [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5571_4.1.0.0",
    "name": "Antiplatelet agents, recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5565_4.13.2.0",
    "name": "Anxiety disorder [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5567_4.4.0.0",
    "name": "Approach to individualization of glycemic targets [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5569_4.4.0.0",
    "name": "Approved weight loss medications [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5571_4.5.0.0",
    "name": "Aspirin dosing [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_4.4.0.0",
    "name": "Aspirin use in people <50 years of age [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5569_4.5.0.0",
    "name": "Assessing efficacy and safety [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5565_4.1.0.0",
    "name": "Assessment of comorbidities [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5567_1.0.0.0",
    "name": "Assessment of glycemic control [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5569_2.0.0.0",
    "name": "Assessment [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5574_1.8.3.0",
    "name": "Autoimmune conditions, celiac disease [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.8.1.0",
    "name": "Autoimmune conditions, recommendations [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.8.2.0",
    "name": "Autoimmune conditions, thyroid Disease [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5565_4.2.0.0",
    "name": "Autoimmune diseases [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_5.2.2.0",
    "name": "Basal insulin",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5570_4.5.2.0",
    "name": "Basal insulin [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5576_4.1.0.0",
    "name": "Bedside blood glucose monitoring, indications [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_4.2.0.0",
    "name": "Bedside blood glucose monitoring, Point-of-care meters [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5571_2.4.2.5",
    "name": "Bedtime dosing [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5569_3.1.0.0",
    "name": "Behavioral therapy [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5572_3.2.5.0",
    "name": "Bladder dysfunction [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5574_1.7.0.0",
    "name": "Blood glucose and A1C goals [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5572_1.8.5.0",
    "name": "Blood pressure [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5570_4.5.4.0",
    "name": "Bolus insulin [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5575_7.1.0.0",
    "name": "Breastfeeding [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5565_4.3.0.0",
    "name": "Cancer [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Carbamazepine [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5566_3.5.0.0",
    "name": "Carbohydrates [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5572_3.2.3.0",
    "name": "Cardiac autonomic neuropathy, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5571_5.2.0.0",
    "name": "Cardiac testing [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5572_1.8.5.0",
    "name": "Cardiovascular disease [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5570_4.4.0.0",
    "name": "Cardiovascular outcomes Trials [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5574_1.9.2.0",
    "name": "Cardiovascular risk, dyslipidemia [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.9.1.0",
    "name": "Cardiovascular risk, hypertension [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.9.3.0",
    "name": "Cardiovascular risk, smoking [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5562_2.1.0.0",
    "name": "Care delivery systems [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5574_1.8.3.0",
    "name": "Celiac disease, recommendations [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.8.3.0",
    "name": "Celiac disease, screening [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5576_4.3.0.0",
    "name": "CGM [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5567_1.0.0.0",
    "name": "CGM [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5577_2.3.0.0",
    "name": "Child care setting, care of young children [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5562_2.2.0.0",
    "name": "Chronic care model [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5572_1.3.0.0",
    "name": "Chronic kidney disease, albuminuria assessment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.4.0.0",
    "name": "Chronic kidney disease, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.5.0.0",
    "name": "Chronic kidney disease, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.3.0.0",
    "name": "Chronic kidney disease, eGFR assessment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.2.0.0",
    "name": "Chronic kidney disease, epidemiology [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.8.1.0",
    "name": "Chronic kidney disease, interventions [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.8.1.0",
    "name": "Chronic kidney disease, nutrition [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.1.0.0",
    "name": "Chronic kidney disease, screening recom. [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.5.0.0",
    "name": "Chronic kidney disease, stages [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.7.0.0",
    "name": "Chronic kidney disease, surveillance [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.1.0.0",
    "name": "Chronic kidney disease, treatment recom. [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.1.0.0",
    "name": "Chronic kidney disease [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.7.0.0",
    "name": "CKD, complications of [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_1.5.0.0",
    "name": "CKD stages [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5571_2.4.2.3",
    "name": "Classes of antihypertensive medications [CVD & risk mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5565_4.4.0.0",
    "name": "Cognitive impairment/dementia [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "interactive_0001688",
    "name": "Combination injectable therapy [tool]"
  },
  {
    "jumpto": "ENAS5571_3.4.1.0",
    "name": "Combination therapy for LDL cholesterol lowering [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5570_4.3.0.0",
    "name": "Combination therapy [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5562_3.5.0.0",
    "name": "Community support [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5565_4.1.0.0",
    "name": "Comorbidities evaluation, assessment [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5570_4.5.6.0",
    "name": "Concentrated insulin products [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5569_4.3.0.0",
    "name": "Concomitant medications [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5561_1.2.0.0",
    "name": "Consensus reports",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5576_2.2.0.0",
    "name": "Considerations on admission [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_4.3.0.0",
    "name": "Continuous glucose monitoring [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5567_1.0.0.0",
    "name": "Continuous glucose monitoring [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5576_8.0.0.0",
    "name": "Continuous subcutaneous insulin infusion [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5575_7.5.0.0",
    "name": "Contraception [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5571_5.1.0.0",
    "name": "Coronary heart disease, screening recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_5.1.0.0",
    "name": "Coronary heart disease, treatment recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5577_2.6.0.0",
    "name": "Correctional institutions, diabetes mgmt. [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5576_5.2.1.0",
    "name": "Critical care setting [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_8.0.0.0",
    "name": "CSII [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5564_4.0.0.0",
    "name": "CVD, prevention [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5567_4.3.1.0",
    "name": "CVD and type 1 diabetes [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_4.3.2.0",
    "name": "CVD and type 2 diabetes [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5572_1.8.5.0",
    "name": "CVD [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5566_3.3.0.0",
    "name": "DASH diet [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5572_1.8.2.0",
    "name": "DCCT [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5565_4.13.3.0",
    "name": "Depression [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5575_1.0.0.0",
    "name": "Diabetes, pregnancy",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5564_5.0.0.0",
    "name": "Diabetes, self-management education & support [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5577_1.0.0.0",
    "name": "Diabetes advocacy, introduction",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5577_2.4.0.0",
    "name": "Diabetes and driving [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5577_2.5.0.0",
    "name": "Diabetes and employment [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5562_1.0.0.0",
    "name": "Diabetes and population health, recommendations",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5576_1.0.0.0",
    "name": "Diabetes care, introduction",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5577_2.2.0.0",
    "name": "Diabetes care, school setting [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5576_2.4.0.0",
    "name": "Diabetes care providers [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complication cardiac function esting",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complication cardiovascular disease",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complication dyslipidemia",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complication nonalcoholic fatty liver disease",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complication obstructive sleep apnea",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complication polycystic ovary syndrome",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complications nephropathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complications neuropathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.5.0.0",
    "name": "Diabetes complications retinopathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5572_1.8.2.0",
    "name": "Diabetes Control and Complications Trial [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5566_6.4.2.0",
    "name": "Diabetes distress, recommendations [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5577_2.6.0.0",
    "name": "Diabetes mgmt. in correctional inst. [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5566_3.9.0.0",
    "name": "Diabetes Prevention Program Outcomes Study [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5564_2.2.0.0",
    "name": "Diabetes Prevention Program [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5562_3.3.0.0",
    "name": "Diabetes self-management education and support [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5574_1.2.0.0",
    "name": "Diabetes Self-mgmt. education & support [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5571_3.7.0.0",
    "name": "Diabetes with statin use [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5572_3.2.2.0",
    "name": "Diabetic autonomic neuropathy, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5576_9.4.0.0",
    "name": "Diabetic ketoacidosis [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5574_1.10.1.0",
    "name": "Diabetic kidney disease, recommendations [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.10.1.0",
    "name": "Diabetic kidney disease, screening [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.10.1.0",
    "name": "Diabetic kidney disease, treatment [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5572_3.2.1.0",
    "name": "Diabetic peripheral neuropathy, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_2.1.0.0",
    "name": "Diabetic retinopathy, recommendations [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_2.2.0.0",
    "name": "Diabetic retinopathy, screening [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_2.3.0.0",
    "name": "Diabetic retinopathy, treatment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "interactive_0001691",
    "name": "Diagnosis of diabetes and prediabetes [tool]"
  },
  {
    "jumpto": "ENAS5569_3.1.0.0",
    "name": "Diet [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5565_4.13.4.0",
    "name": "Disordered eating behavior [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5564_5.0.0.0",
    "name": "DM self-management education & support [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5572_3.2.1.0",
    "name": "DPN, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5564_2.2.0.0",
    "name": "DPP [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "interactive_0001693",
    "name": "Drug-specific & pt. factors in T2DM Tx [tool]"
  },
  {
    "jumpto": "ENAS5566_2.1.0.0",
    "name": "DSMES, recommendations [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5562_3.3.0.0",
    "name": "DSMES [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Duloxetine [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5574_1.9.2.0",
    "name": "Dyslipidemia, pathophysiology [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.9.2.0",
    "name": "Dyslipidemia, recommendations [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.9.2.0",
    "name": "Dyslipidemia, treatment [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_5.2.0.0",
    "name": "E-cigarettes [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5572_1.3.0.0",
    "name": "eGFR assessment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5573_8.0.0.0",
    "name": "End-of-life care in older adults, recommendations",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5576_9.1.0.0",
    "name": "Enteral/parenteral feedings, insulin dosing [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_9.1.0.0",
    "name": "Enteral feedings [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5572_3.3.5.0",
    "name": "Erectile dysfunction [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5561_1.3.0.0",
    "name": "Evidence-grading system ADA",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5566_4.8.3.0",
    "name": "Exercise and autonomic neuropathy [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.3.0.0",
    "name": "Exercise and children [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.8.4.0",
    "name": "Exercise and diabetic kidney disease [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.8.2.0",
    "name": "Exercise and peripheral neuropathy [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.8.1.0",
    "name": "Exercise and retinopathy [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.8.1.0",
    "name": "Exercise in complications of DM [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_3.7.0.0",
    "name": "Fats [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5565_4.5.0.0",
    "name": "Fatty liver disease [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5562_3.2.0.0",
    "name": "Food insecurity [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5572_4.4.0.0",
    "name": "Foot care, patient education [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_4.1.0.0",
    "name": "Foot care, recommendations [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_4.5.0.0",
    "name": "Foot care, treatment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5565_4.7.0.0",
    "name": "Fractures [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Gabapentin [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_3.2.4.0",
    "name": "Gastrointestinal neuropathies, diagnosis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_3.3.4.0",
    "name": "Gastroparesis [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_3.2.5.0",
    "name": "Genitourinary disturbances [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5575_7.3.0.0",
    "name": "Gestational diabetes mellitus & T2D [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.2.1.0",
    "name": "Gestational diabetes mellitus, initial testing [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.2.0.0",
    "name": "Gestational diabetes mellitus, lifestyle management [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.3.0.0",
    "name": "Gestational diabetes mellitus, medical nutrition therapy [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.1.0.0",
    "name": "Gestational diabetes mellitus, mgmt. [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.2.2.0",
    "name": "Gestational diabetes mellitus, postpartum follow-up [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_1.0.0.0",
    "name": "Gestational diabetes mellitus [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5567_5.2.2.0",
    "name": "Glucagon [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5576_9.2.0.0",
    "name": "Glucocorticoid therapy [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5572_1.8.4.0",
    "name": "Glucose-lowering medications, in Chronic kidney disease",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5569_4.1.0.0",
    "name": "Glucose-lowering medications [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5576_3.2.0.0",
    "name": "Glucose abnormalities, definition [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5567_3.0.0.0",
    "name": "Glucose Assessment [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5575_3.3.0.0",
    "name": "Glucose monitoring [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5572_1.8.2.0",
    "name": "Glycemia, Chronic kidney disease in [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5576_3.3.0.0",
    "name": "Glycemic control, moderate versus tight [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5574_1.7.0.0",
    "name": "Glycemic control [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5567_4.4.0.0",
    "name": "Glycemic recommendations for many nonpregnant adults with diabetes [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5575_3.4.0.0",
    "name": "Glycemic targets, A1C in pregnancy [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_3.3.0.0",
    "name": "Glycemic targets, glucose monitoring [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_3.2.0.0",
    "name": "Glycemic targets, insulin physiology [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_3.1.0.0",
    "name": "Glycemic targets, recommendations [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5576_3.1.0.0",
    "name": "Glycemic targets in hospitalized patients, recommendations [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5565_4.8.0.0",
    "name": "Hearing impairment [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5565_3.0.0.0",
    "name": "Hepatitis B",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5565_4.5.0.0",
    "name": "Hepatocellular carcinoma [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5571_3.3.2.0",
    "name": "High-intensity and moderate-intensity statin therapy [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5565_4.9.0.0",
    "name": "HIV [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_2.2.0.0",
    "name": "Hospital care delivery standards, admission [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_2.4.0.0",
    "name": "Hospital care delivery standards, diabetes care providers [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_2.3.0.0",
    "name": "Hospital care delivery standards, physician order entry [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_2.5.0.0",
    "name": "Hospital care delivery standards, quality assurance standards [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_2.1.0.0",
    "name": "Hospital care delivery standards, recommendations [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5565_4.4.0.0",
    "name": "Hyperglycemia/hypoglycemia and Cognitive impairment [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5571_2.4.3.0",
    "name": "Hyperkalemia and AKI [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5576_9.4.0.0",
    "name": "Hyperosmolar hyperglycemic state [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5574_1.9.1.0",
    "name": "Hypertension, screening [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.9.1.0",
    "name": "Hypertension, treatment [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5571_2.1.0.0",
    "name": "Hypertension/blood pressure control [CVD & risk mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "interactive_0001792",
    "name": "Hypertension treatment [tool]"
  },
  {
    "jumpto": "ENAS5574_1.9.1.0",
    "name": "Hypertension [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5572_1.8.5.0",
    "name": "Hypertension [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5576_6.3.0.0",
    "name": "Hypoglycemia, predictors [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_6.4.0.0",
    "name": "Hypoglycemia, prevention [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_6.1.0.0",
    "name": "Hypoglycemia, recommendations [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5567_5.1.0.0",
    "name": "Hypoglycemia, recommendations [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5576_6.2.0.0",
    "name": "Hypoglycemia, triggering events [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5566_4.7.0.0",
    "name": "Hypoglycemia and physical activity [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5573_3.0.0.0",
    "name": "Hypoglycemia in older adults, recommendations",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5567_5.3.0.0",
    "name": "Hypoglycemia prevention [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_5.2.1.0",
    "name": "Hypoglycemia treatment, overview [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5576_11.1.0.0",
    "name": "Hypoglycemic admissions, older adults [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5565_4.10.0.0",
    "name": "Hypogonadism [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_6.2.0.0",
    "name": "Iatrogenic hypoglycemia [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5565_3.0.0.0",
    "name": "Immunizations",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Incretin-based therapies, in older adults",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5571_4.6.0.0",
    "name": "Indications for P2Y12 use [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_2.3.4.0",
    "name": "Individualization of treatment targets [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_2.4.2.2",
    "name": "Initial number of antihypertensive medications [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5570_4.2.0.0",
    "name": "Initial therapy [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5571_3.3.2.0",
    "name": "Initiating statin therapy based on risk [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5575_3.2.0.0",
    "name": "Insulin physiology [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Insulin secretagogues, in older adults",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5576_5.2.1.0",
    "name": "Insulin therapy, critical care setting [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Insulin therapy, in older adults",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5576_5.2.2.0",
    "name": "Insulin therapy, noncritical care setting [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_5.2.4.0",
    "name": "Insulin therapy, transitioning IV to SQ insulin [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_5.2.3.0",
    "name": "Insulin therapy, type 1 diabetes [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5570_2.2.0.0",
    "name": "Insulin therapy [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5570_4.5.1.0",
    "name": "Insulin therapy [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5575_5.1.0.0",
    "name": "Insulin use [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.4.4.0",
    "name": "Insulin [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5567_1.0.0.0",
    "name": "Intensive insulin regimens [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5567_6.0.0.0",
    "name": "Intercurrent illness [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5576_5.2.1.0",
    "name": "Intravenous insulin infusion [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5571_1.0.0.0",
    "name": "Introduction [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5565_4.6.0.0",
    "name": "Islet autotransplantation [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5575_7.1.0.0",
    "name": "Lactation [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5562_3.4.0.0",
    "name": "Language barriers [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5571_5.4.0.0",
    "name": "Lifestyle and pharmacologic interventions [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5564_2.6.0.0",
    "name": "Lifestyle interventions, cost-effectiveness [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5564_2.3.0.0",
    "name": "Lifestyle interventions, nutrition [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5564_2.4.0.0",
    "name": "Lifestyle interventions, physical activity [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5564_2.5.0.0",
    "name": "Lifestyle interventions, technology assistance [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5569_3.3.0.0",
    "name": "Lifestyle interventions [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5564_2.2.0.0",
    "name": "Lifestyle interventions [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5571_3.1.0.0",
    "name": "Lifestyle intervention [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5566_1.0.0.0",
    "name": "Lifestyle management",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5575_4.2.0.0",
    "name": "Lifestyle management [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5573_5.0.0.0",
    "name": "Lifestyle Management [Older Adults]",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5571_3.1.0.0",
    "name": "Lipid management [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.2.0.0",
    "name": "lipid panel [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5569_3.2.0.0",
    "name": "Look AHEAD trial [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5572_4.2.0.0",
    "name": "LOPS, evaluation [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5566_3.3.0.0",
    "name": "Macronutrient distribution [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_2.4.2.0",
    "name": "Management of new-onset diabetes in overweight youth",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_3.3.0.0",
    "name": "Meal planning [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5567_2.3.0.0",
    "name": "Mean glucose levels for specified A1C levels [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5565_1.0.0.0",
    "name": "Medical evaluation [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_7.0.0.0",
    "name": "Medical nutrition therapy, hospital [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5575_4.3.0.0",
    "name": "Medical nutrition therapy [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5565_2.0.0.0",
    "name": "Medical nutrition therapy [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5566_2.4.0.0",
    "name": "Medicare [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5576_10.0.0.0",
    "name": "Medication reconciliation [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5569_4.4.0.0",
    "name": "Medications, long-term treatment [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5569_4.4.0.0",
    "name": "Medications, short-term treatment [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5565_4.4.0.0",
    "name": "Mediterranean diet [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5566_6.5.0.0",
    "name": "Mental health specialist [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5571_2.3.3.0",
    "name": "Meta-analyses of trials [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5574_2.4.3.0",
    "name": "Metabolic surgery",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5569_6.2.0.0",
    "name": "Metabolic surgery, adverse effects [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5569_6.1.0.0",
    "name": "Metabolic surgery, recommendations [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Metformin, in older adults",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5575_4.4.3.0",
    "name": "Metformin [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.1.0.0",
    "name": "Mgmt., gestational diabetes mellitus [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_5.1.0.0",
    "name": "Mgmt., preexisting T1D & T2D [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5566_3.9.0.0",
    "name": "Micronutrients and supplements [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_1.10.1.0",
    "name": "Microvascular complications, diabetic kidney disease [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.10.3.0",
    "name": "Microvascular complications, neuropathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.10.2.0",
    "name": "Microvascular complications, retinopathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_3.1.0.0",
    "name": "MNT recommendations [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5565_2.0.0.0",
    "name": "MNT [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_3.3.0.0",
    "name": "Moderate versus tight glycemic control [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5566_3.5.0.0",
    "name": "Modified plate method [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5571_2.4.2.4",
    "name": "Multiple-drug therapy [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5562_3.3.0.0",
    "name": "National diabetes education program [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5573_2.0.0.0",
    "name": "Neurocognitive function in older adults, recommendations",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Neuropathic pain, treatment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_3.3.1.0",
    "name": "Neuropathy, glycemic control [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_3.1.0.0",
    "name": "Neuropathy, recommendations [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5572_3.3.1.0",
    "name": "Neuropathy, treatment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5574_1.10.3.0",
    "name": "Neuropathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5565_4.5.0.0",
    "name": "Nonalcoholic chronic liver disease [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_5.2.2.0",
    "name": "Noncritical care setting [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_5.3.0.0",
    "name": "Noninsulin therapies [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5574_1.3.0.0",
    "name": "Nutrition therapy",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_3.2.0.0",
    "name": "Nutrition therapy, goals for adults with DM [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_3.1.0.0",
    "name": "Nutrition therapy [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5564_2.3.0.0",
    "name": "Nutrition [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5569_1.0.0.0",
    "name": "Obesity management, introduction",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5565_4.11.0.0",
    "name": "Obstructive sleep apnea [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_11.1.0.0",
    "name": "Older adults, hypoglycemic admissions [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5573_1.0.0.0",
    "name": "Older adults, recommendations",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5573_4.1.0.0",
    "name": "Older adults, treatment recommendations",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5571_3.2.0.0",
    "name": "Ongoing therapy and monitoring with",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5575_4.1.0.0",
    "name": "Oral glucose tolerance test [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5572_3.3.3.0",
    "name": "Orthostatic hypotension, treatment [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5571_3.6.1.0",
    "name": "Other combination therapy, recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5570_1.0.0.0",
    "name": "Overview",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5571_2.1.0.0",
    "name": "Overview [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5570_4.5.1.0",
    "name": "Overview [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5569_2.0.0.0",
    "name": "Overweight and obesity, treatment options",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5572_4.3.0.0",
    "name": "PAD, evaluation [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5565_4.6.0.0",
    "name": "Pancreatitis [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_9.1.0.0",
    "name": "Parenteral feedings [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5565_1.0.0.0",
    "name": "Patient-centered collaborative care [Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5562_2.3.0.0",
    "name": "Patient-centered medical home [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5574_3.0.0.0",
    "name": "Pediatric to adult care, transition [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5565_4.12.0.0",
    "name": "Periodontal disease [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_9.3.0.0",
    "name": "Perioperative care [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5570_2.1.0.0",
    "name": "Pharm. therapy for type 1 diabetes, recommendations [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5571_2.4.2.1",
    "name": "Pharmacologic interventions, recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5564_3.0.0.0",
    "name": "Pharmacologic interventions [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5575_4.4.4.0",
    "name": "Pharmacologic therapy, insulin [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.4.3.0",
    "name": "Pharmacologic therapy, metformin [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_4.4.1.0",
    "name": "Pharmacologic therapy, overview [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Pharmacologic therapy, recommendations",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5575_4.4.2.0",
    "name": "Pharmacologic therapy, sulfonylureas [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5570_2.1.0.0",
    "name": "Pharmacologic therapy for type 1 Diabetes [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5570_4.1.0.0",
    "name": "Pharmacologic therapy for type 2 Diabetes, recommendations [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5570_4.1.0.0",
    "name": "Pharmacologic therapy for type 2 Diabetes [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5569_4.2.0.0",
    "name": "Pharmacotherapy, antihyperglycemic therapy [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5569_4.3.0.0",
    "name": "Pharmacotherapy, concomitant medications [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5569_4.1.0.0",
    "name": "Pharmacotherapy, recommendations [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5566_4.4.0.0",
    "name": "Physical activity, frequency and type [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.2.0.0",
    "name": "Physical activity, recommendations [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_1.4.0.0",
    "name": "Physical activity and exercise",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_4.5.0.0",
    "name": "Physical activity and glycemic control [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_4.7.0.0",
    "name": "Physical activity and hypoglycemia [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5569_3.1.0.0",
    "name": "Physical activity [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5564_2.4.0.0",
    "name": "Physical activity [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5576_2.3.0.0",
    "name": "Physician order entry [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5566_3.3.0.0",
    "name": "Plant-based diets [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5565_3.0.0.0",
    "name": "Pneumococcal pneumonia",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5576_4.2.0.0",
    "name": "Point-of-care meters [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5567_2.1.0.0",
    "name": "Point-of-care testing [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5575_7.5.0.0",
    "name": "Postpartum care, contraception [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.3.0.0",
    "name": "Postpartum care, gestational diabetes mellitus & T2D [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.1.0.0",
    "name": "Postpartum care, lactation [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.4.0.0",
    "name": "Postpartum care, preexisting type 1 and type 2 diabetes [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.2.2.0",
    "name": "Postpartum follow-up [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_3.3.0.0",
    "name": "Postprandial monitoring [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5570_2.3.0.0",
    "name": "Pramlintide [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5566_4.6.0.0",
    "name": "Pre-exercise evaluation [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5575_2.1.0.0",
    "name": "Preconception counseling, recommendations [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_2.2.0.0",
    "name": "Preconception testing [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5576_6.3.0.0",
    "name": "Predictors of hypoglycemia [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5575_5.2.0.0",
    "name": "Preeclampsia and aspirin [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_5.1.0.0",
    "name": "Preexisting T1D & T2D mgmt., insulin use [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_5.2.0.0",
    "name": "Preexisting T1D & T2D mgmt., preeclampsia and aspirin [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_5.3.0.0",
    "name": "Preexisting T1D & T2D mgmt., type 1 diabetes [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_5.4.0.0",
    "name": "Preexisting T1D & T2D mgmt., type 2 diabetes [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_7.4.0.0",
    "name": "Preexisting type 1 and type 2 diabetes [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Pregabalin [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5575_1.0.0.0",
    "name": "Pregnancy, diabetes",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5575_3.1.0.0",
    "name": "Pregnancy, glycemic targets [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5571_2.3.5.0",
    "name": "Pregnancy and antihypertensive medications",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5575_6.0.0.0",
    "name": "Pregnancy and drug considerations [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5570_4.5.5.0",
    "name": "Premixed insulin [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5575_3.3.0.0",
    "name": "Preprandial testing [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5576_11.1.0.0",
    "name": "Prev. admissions & readmissions [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_11.1.0.0",
    "name": "Prev. hypoglycemic adm. in older adults [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_11.2.0.0",
    "name": "Preventing readmissions [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5564_4.0.0.0",
    "name": "Prevention of CVD [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5564_1.0.0.0",
    "name": "Prevention or delay of type 2 diabetes, introduction",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5571_3.3.3.2",
    "name": "Primary prevention, age <40 years and/or type 1 diabetes [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.3.3.1",
    "name": "Primary prevention, age >40 years & older (Patients w/o ASCVD) [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5561_2.0.0.0",
    "name": "Professional Practice Committee (PPC)",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5566_3.6.0.0",
    "name": "Protein [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5565_4.13.1.0",
    "name": "Psychosocial/emotional disorders [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5566_6.2.0.0",
    "name": "Psychosocial care [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_2.6.0.0",
    "name": "Psychosocial factors",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_6.4.2.0",
    "name": "Psychosocial issues, diabetes distress [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_1.6.0.0",
    "name": "Psychosocial issues, recommendations [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_6.2.0.0",
    "name": "Psychosocial issues, recommendations [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_1.6.0.0",
    "name": "Psychosocial issues, screening [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5566_6.3.0.0",
    "name": "Psychosocial issues, screening [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5576_2.5.0.0",
    "name": "Quality assurance standards [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5571_2.3.2.0",
    "name": "Randomized controlled trials of intensive versus standard BP control [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.3.2.0",
    "name": "Recommendations for statin and combination treatment in adults with diabetes [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5572_1.8.3.0",
    "name": "Renal effects of glucose-lowering medications [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5571_2.4.4.0",
    "name": "Resistant hypertension [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5574_1.10.2.0",
    "name": "Retinopathy [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5561_3.2.1.0",
    "name": "Revision, section 1",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.2.0",
    "name": "Revisions, section 2",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.3.0",
    "name": "Revisions, section 3",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.4.0",
    "name": "Revisions, section 4",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.5.0",
    "name": "Revisions, section 5",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.6.0",
    "name": "Revisions, section 6",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.7.0",
    "name": "Revisions, section 7",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.8.0",
    "name": "Revisions, section 8",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.9.0",
    "name": "Revisions, section 9",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.10.0",
    "name": "Revisions, section 10",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.11.0",
    "name": "Revisions, section 11",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.12.0",
    "name": "Revisions, section 12",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.13.0",
    "name": "Revisions, section 13",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.14.0",
    "name": "Revisions, section 14",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.15.0",
    "name": "Revisions, section 15",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.16.0",
    "name": "Revisions, section 16",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5561_3.2.1.0",
    "name": "Revisions summary",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5571_4.2.0.0",
    "name": "Risk reduction [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5574_1.5.0.0",
    "name": "School and child care [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5577_2.2.0.0",
    "name": "School setting [Diab. Adv.]",
    "guidelineID": 34
  },
  {
    "jumpto": "ENAS5561_1.2.0.0",
    "name": "Scientiﬁc reviews",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5574_2.2.0.0",
    "name": "Screening and Diagnosis",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5571_2.2.0.0",
    "name": "Screening and diagnosis [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_5.3.0.0",
    "name": "Screening asymptomatic patients [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.3.4.0",
    "name": "Secondary preventions (patients w/ASCVD) [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5576_8.0.0.0",
    "name": "Self-management, hospital [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5564_5.0.0.0",
    "name": "Self-management education & support [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5567_1.0.0.0",
    "name": "Self-monitoring of blood glucose [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5565_4.13.5.0",
    "name": "Serious mental illness [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5567_4.4.0.0",
    "name": "Setting and Modifying A1C Goals [Glycemic Targets]",
    "guidelineID": 24
  },
  {
    "jumpto": "ENAS5566_5.2.0.0",
    "name": "Smoking cessation, recommendations [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5566_5.2.0.0",
    "name": "Smoking cessation [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5574_1.9.3.0",
    "name": "Smoking [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Sodium-Glucose Cotransporter 2 Inhibitors, in older adults",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5566_3.8.0.0",
    "name": "Sodium [Lifestyle Mgmt.]",
    "guidelineID": 23
  },
  {
    "jumpto": "ENAS5576_9.1.0.0",
    "name": "Special situations, standards [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5561_1.2.0.0",
    "name": "Standards of care statements",
    "guidelineID": 18
  },
  {
    "jumpto": "ENAS5571_3.6.2.0",
    "name": "Statin and Fibrate [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.6.3.0",
    "name": "Statin and Niacin [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.8.0.0",
    "name": "Statins and cognitive function [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.4.1.0",
    "name": "Statins and Ezetimibe [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.4.2.0",
    "name": "Statins and PCSK9 inhibitors [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_3.3.1.0",
    "name": "Statin treatment, recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5576_10.0.0.0",
    "name": "Structured discharge communication [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5575_4.4.2.0",
    "name": "Sulfonylureas [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5570_3.0.0.0",
    "name": "Surgical treatment for",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5562_2.3.0.0",
    "name": "System-level improvement strategies [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5564_1.0.0.0",
    "name": "T2DM prevention, introduction",
    "guidelineID": 21
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Tapentadol [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5564_2.5.0.0",
    "name": "Tech. assist. to deliver lstyle. intervent. [T2DM Prev.]",
    "guidelineID": 21
  },
  {
    "jumpto": "interactive_0001780",
    "name": "Testing in asymptomatic adults [tool]"
  },
  {
    "jumpto": "ENAS5565_4.10.0.0",
    "name": "Testosterone levels [Eval. of Comorbidities]",
    "guidelineID": 22
  },
  {
    "jumpto": "ENAS5573_6.0.0.0",
    "name": "Thiazolidinediones, in older adults",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5574_1.8.2.0",
    "name": "Thyroid Disease [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Tramadol [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5574_3.0.0.0",
    "name": "Transition from pediatric to adult care [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5576_10.0.0.0",
    "name": "Transition from the acute care setting [Hospital Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5576_5.2.4.0",
    "name": "Transitioning IV to SQ insulin [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5571_4.3.0.0",
    "name": "Treatment considerations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5562_3.1.0.0",
    "name": "Treatment for socila context, recommendations [Population Health]",
    "guidelineID": 19
  },
  {
    "jumpto": "ENAS5571_2.3.1.0",
    "name": "Treatment goals, recommendations [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5569_4.4.0.0",
    "name": "Treatment of obesity, medications [Obesity Mgmt.]",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5571_3.5.0.0",
    "name": "Treatment of other lipoprotein fractions or targets [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5569_2.0.0.0",
    "name": "Treatment options, overweight and obesity",
    "guidelineID": 26
  },
  {
    "jumpto": "ENAS5573_7.0.0.0",
    "name": "Treatment recommendations in nursing facilities, older adults in",
    "guidelineID": 30
  },
  {
    "jumpto": "ENAS5571_2.4.1.0",
    "name": "Treatment strategies, lifestyle intervention [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5571_2.4.2.1",
    "name": "Treatment strategies, pharmacologic interventions [CVD & Risk Mgmt]",
    "guidelineID": 28
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Tricyclic antidepressants [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5574_1.8.1.0",
    "name": "Type 1 diabetes, autoimmune conditions [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.8.3.0",
    "name": "Type 1 diabetes, celiac disease [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.2.0.0",
    "name": "Type 1 diabetes, diabetes self-mgmt. education & support [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.7.0.0",
    "name": "Type 1 diabetes, glycemic control [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.1.0.0",
    "name": "Type 1 diabetes, introduction [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.6.0.0",
    "name": "Type 1 diabetes, psychosocial issues [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.5.0.0",
    "name": "Type 1 diabetes, school and child care [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_1.8.2.0",
    "name": "Type 1 diabetes, thyroid Disease [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5576_5.2.3.0",
    "name": "Type 1 diabetes [Diab. Care]",
    "guidelineID": 33
  },
  {
    "jumpto": "ENAS5575_5.3.0.0",
    "name": "Type 1 diabetes [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5570_3.0.0.0",
    "name": "type 1 diabetes [Glycemic Tx]",
    "guidelineID": 27
  },
  {
    "jumpto": "ENAS5574_2.3.0.0",
    "name": "Type 2 diabetes, diagnostic challenges [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.1.0.0",
    "name": "Type 2 diabetes, introduction [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.4.1.0",
    "name": "Type 2 diabetes, lifestyle management [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.4.1.0",
    "name": "Type 2 diabetes, management [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.4.1.0",
    "name": "Type 2 diabetes, pharmacologic management [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5574_2.1.0.0",
    "name": "Type 2 diabetes, screening and diagnosis [Child. & Adol.]",
    "guidelineID": 31
  },
  {
    "jumpto": "ENAS5575_5.4.0.0",
    "name": "Type 2 diabetes [DM in Preg.]",
    "guidelineID": 32
  },
  {
    "jumpto": "ENAS5572_3.3.2.0",
    "name": "Venlafaxine [Microvasc. Compli.]",
    "guidelineID": 29
  },
  {
    "jumpto": "ENAS5566_3.4.0.0",
    "name": "Weight management [Lifestyle Mgmt.]",
    "guidelineID": 23
  }
]